Physician profile
Larry Crisco
NPI 1952395782
$41,428.14
in general payments reported to CMS, 2019-2025
70 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,331 · 2020: $2,620 · 2021: $10K · 2022: $5,946 · 2023: $3,699 · 2024: $3,299 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $7,085 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,457.39 |
| Travel and Lodging | $7,085.34 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,808.14 | 2021-2025 | Onyx Frontier, Resolute Onyx, Hawkone |
| Avinger INC. | $9,350.62 | 2019-2022 | |
| Boston Scientific Corporation | $5,149.77 | 2019-2025 | General - Vascular Intervention, Watchman Flx, Hornet 10 |
| Abiomed | $1,847.65 | 2019-2025 | Impella |
| Shockwave Medical, INC | $1,627.38 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $1,579.00 | 2019-2025 | Dragonfly Opstar, Coroflow, Esprit |
| Medtronic Vascular, INC. | $1,297.67 | 2019-2020 | |
| Endologix LLC | $804.75 | 2021-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Philips North America LLC | $564.02 | 2021-2025 | (Br5) Peripheral Ivus, Eagle Eye, (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $468.51 | 2019-2025 | |
| Cms Imaging, INC. | $456.22 | 2022 | |
| Merck Sharp & Dohme LLC | $377.54 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $374.66 | 2019-2023 | |
| Edwards Lifesciences Corporation | $364.82 | 2020-2025 | Sapien 3 Ultra Resilia |
| Biotronik INC. | $363.13 | 2019-2022 |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $361.73 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $309.44 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $296.42 | 2019-2023 | Camzyos |
| Canon Medical Systems USA, INC. | $273.22 | 2022 | |
| Janssen Pharmaceuticals, INC | $265.33 | 2019-2024 | Xarelto |
| Angiodynamics, INC. | $237.57 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.25 | 2020-2025 | Jardiance |
| Cardiva Medical, INC. | $212.90 | 2022-2024 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals Lp | $189.39 | 2019-2025 | Farxiga |
| Change Healthcare Technologies, LLC | $188.32 | 2020 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $180.67 | 2019 | |
| Opsens INC. | $174.65 | 2019-2020 | |
| Teleflex LLC | $149.35 | 2024-2025 | Manta, Orsiro Mission |
| Esperion Therapeutics, INC. | $143.13 | 2020-2024 | Nexletol |
| Amarin Pharma, INC. | $103.19 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.37 | 2019-2025 | Lifevest |
| Acist Medical Systems, INC. | $92.75 | 2019-2025 | |
| Novo Nordisk INC | $82.52 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Alnylam Pharmaceuticals INC. | $82.08 | 2025 | Amvuttra |
| Stryker Corporation | $76.32 | 2025 | Limflow System, Artix Mt |
| Kestra Medical Technology Services, INC. | $75.17 | 2025 | Assure Wcd |
| Silk Road Medical, INC. | $70.12 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Celonova Biosciences, INC. | $68.93 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $65.33 | 2019-2025 | Evkeeza |
| Cardinal Health 200 LLC | $64.71 | 2019-2020 | |
| Chiesi USA, INC. | $61.97 | 2020-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $60.60 | 2021-2023 | Arcalyst |
| Bard Peripheral Vascular, INC. | $58.90 | 2021-2023 | Crosser Iq |
| Cardiovascular Systems INC. | $56.10 | 2019-2022 | |
| Heartflow, INC. | $48.88 | 2023 | Ffrct |
| Vital Connect, INC | $42.35 | 2025 | Vitalpatch Rtm |
| Biosense Webster, INC. | $37.43 | 2021-2023 | Carto 3 |
| Neuros Medical, INC. | $36.67 | 2025 | Altius |
| Reflow Medical INC | $35.73 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.19 | 2021-2025 | |
| Corindus INC. | $33.15 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $33.14 | 2021 | |
| Venclose INC. | $32.22 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $27.52 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $27.39 | 2022 | |
| Scpharmaceuticals INC. | $27.38 | 2024 | |
| Cordis US Corp. | $27.30 | 2025 | Mynx Control |
| Genzyme Corporation | $24.65 | 2022 | |
| United Therapeutics Corporation | $23.90 | 2025 | Tyvaso |
| Lexicon Pharmaceuticals, INC. | $21.33 | 2024 | |
| Celgene Corporation | $19.36 | 2025 | |
| Biocompatibles, INC. | $19.28 | 2019 | |
| Ge Healthcare | $18.60 | 2019 | |
| Getinge USA Sales, LLC | $17.64 | 2019 | |
| Atricure, INC. | $15.59 | 2024 | |
| Cvrx, INC. | $15.28 | 2022 | |
| Convatec INC. | $15.26 | 2023 | |
| Cook Medical LLC | $13.55 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.04 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Crisco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.